T 0163/08 (GLP-1 to improve reperfusion/AMYLIN PHARMACEUTICALS, INC.) of 06.10.2010
- European Case Law Identifier
- ECLI:EP:BA:2010:T016308.20101006
- Date of decision
- 6 October 2010
- Case number
- T 0163/08
- Online on
- 8 April 2011
- Petition for review of
- -
- Application number
- 00926404.5
- IPC class
- A61K 38/26
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
- Applicant name
- AMYLIN PHARMACEUTICALS, INC.
- Opponent name
- Novo Nordisk A/S
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 114(2)European Patent Convention Art 123(2)
- Keywords
- Admission of late-filed documents (yes)
Added subject-matter (no)
Sufficiency of disclosure (yes)
Novelty (yes)
Inventive step (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of claims 1 to 11 of the main request filed with the appellant's letter of 15 June 2006 and the description as granted.